Cover Image

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar

Lee S Schwartzberg,1,2 Lincy S Lal,3 Sanjeev Balu,4 Kim Campbell,4 Lee Brekke,3 Caitlin Elliott,3 Stephanie Korrer3 1West Cancer Center, Memphis, TN, USA; 2Division of Hematology and Oncology, University of Tennessee, Memphis, TN, USA; 3Health Economics and Outcomes Research, Optum, Eden Prairie, MN...

Full description

Saved in:

Bibliographic Details
Main Authors:	Schwartzberg LS (Author), Lal LS (Author), Balu S (Author), Campbell K (Author), Brekke L (Author), Elliott C (Author), Korrer S (Author)
Format:	Book
Published:	Dove Medical Press, 2018-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review
by: Girma Tekle Gebremariam, et al.
Published: (2022)

Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers
by: Choi C, et al.
Published: (2018)

Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis
by: Kerry Mansell, et al.
Published: (2019)

Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis
by: Kerry Mansell, et al.
Published: (2019)

Factors Associated with Absolute Neutrophil Count Dynamics and Docetaxel-Adryamicin-Cyclophosphamide (TAC) Chemotherapy Induced Neutropenia During Extended Filgrastim Administration in Breast Cancer Patients
by: Ami Ashariati, et al.
Published: (2022)

EFFECTIVENESS AND SAFETY OF FILGRASTIM BIOANALOGUE IN TREATMENT AND PROPHYLAXIS OF GRANULOCYTOPENIA IN CHILDREN
by: A.A. Maschan, et al.
Published: (2010)

EFFECTIVENESS AND SAFETY OF FILGRASTIM BIOANALOGUE IN TREATMENT AND PROPHYLAXIS OF GRANULOCYTOPENIA IN CHILDREN
by: A.A. Maschan, et al.
Published: (2010)

ANALYSIS AND RELEVANCE OF DATA ABOUT ADDITIONAL STABILITY OF NIVESTIM™ ( FILGRASTIM SOLUTION FOR INJECTION )
by: António Melo Gouveia
Published: (2012)

Prediction of Survival Benefit of Filgrastim in Adult and Pediatric Patients With Acute Radiation Syndrome
by: John Harrold, et al.
Published: (2020)

Filgrastim Induced Severe Leukocytosis in Sepsis-Associated Leukopenia: A Case Repor
by: Foroud Shahbazi, et al.
Published: (2019)

Efficacy and safety of peg-filgrastim as primary prophylaxis following pediatric dose-intensive chemotherapy: A randomized controlled trial
by: Jagdish Prasad Meena, et al.
Published: (2024)

Cytokine Kinetics in Febrile Neutropenic Children: Insights on the Usefulness as Sepsis Biomarkers, Influence of Filgrastim, and Behavior of the IL-23/IL-17 Pathway
by: Orlei Ribeiro de Araujo, et al.
Published: (2017)

Rescate medular con filgrastim y ácido folínico en intoxicación por metotrexato
by: Marlon Villacís Aveiga, et al.
Published: (2019)

A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects
by: Adar L, et al.
Published: (2015)

ANÁLISE E RELEVÂNCIA DOS DADOS DE ESTABILIDADE ADICIONAIS DO NIVESTIM™ (FILGRASTIM SOLUÇÃO INJETÁVEL)
by: António de Melo Gouveia
Published: (2012)

A comparison of the effect of xinruibai versus filgrastim on hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation
by: Qixiang Ye, et al.
Published: (2018)

NEUTROPENIA FEBRIL EN PEDIATRIA Febrile Neutropenia in Pedriatrics
by: Pio Lopez, et al.
Published: (2008)

Febrile neutropenia recurrence after chemotherapy in patients with breast cancer
by: Simone Yuriko Kameo, Glebson Moura Silva, Namie Okino Sawada, Mary Elizabeth de Santana
Published: (2020)

Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
by: Federica Cennamo, et al.
Published: (2021)

The risk factors for febrile neutropenia during chemotherapy in children with malignancy
by: Rini Sulviani, et al.
Published: (2007)

Post chemotherapy febrile neutropenia. Length of stay and experience in our population
by: Íñigo Pérez-Heras, et al.
Published: (2020)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
by: Doaa Naeem, et al.
Published: (2018)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
by: José C. Álvarez, et al.
Published: (2021)

Comparison of CISNE and MASCC Score in Predicting Complications on Post Chemotherapy Febrile Neutropenia
by: Sharifah Shakinah, et al.
Published: (2024)

Low albumin at the onset of febrile neutropenia predicts adverse outcome in pediatric febrile neutropenia
by: Manideepa Maji, et al.
Published: (2022)

Artigo: oral vs. intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy Article: oral vs. intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy
by: Viroj Wiwanitkit
Published: (2010)

Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy
by: Talita Garcia do Nascimento, et al.
Published: (2014)

Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases
by: Weycker Derek, et al.
Published: (2013)

Impact of malnutrition on febrile neutropenia in children with acute lymphoblastic leukemia during induction phase chemotherapy
by: Marshalla Agnes, et al.
Published: (2018)

Voriconazole in Prevention and Treatment of Febrile Neutropenia
by: Hamidreza Taghva Masoumi, et al.
Published: (2018)

Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
by: Karen A. Monuszko, et al.
Published: (2021)

Outpatient management of febrile neutropenia in children with cancer
by: Ottavio Ziino, et al.
Published: (2011)

Chemotherapy adjuvant and chemotherapy-induced neutropenia
by: Yiu-Tai Li, et al.
Published: (2022)

Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor
by: Alshari O, et al.
Published: (2021)

Effect of an education program on knowledge, self-care behavior and handwashing competence on prevention of febrile neutropenia among breast cancer patients receiving Doxorubicin and Cyclophosphamide in Chemotherapy Day Centre
by: Wai Chi Mak, et al.
Published: (2015)

Predictors of mortality in pediatric oncology patients with febrile neutropenia
by: Aditya Dabas, et al.
Published: (2022)

Optimizing Empiric Vancomycin Use in Febrile Neutropenia Patients
by: Nicole Tadros, et al.
Published: (2021)

Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia
by: Nagua Giurici, et al.
Published: (2011)

The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma
by: Judith A. E. M. Zecha, et al.
Published: (2022)

Pharmacokinetics of Vancomycin among Patients with Chemotherapy-Associated Febrile Neutropenia: Which Would Be the Best Dosing to Obtain Appropriate Exposure?
by: Daniel Parra González, et al.
Published: (2022)